5,6,7,8-Tetrahydro-1,7-naphthyridine dihydrochloride, 95.0%, 100mg

(S)-4-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one, 98.0%, 1g

7-Chloro-benzo[1,3]dioxole-5-carbaldehyde, 1g

2-Methylpyridine N-Oxide>99.0%(GC)25g

Methyl4-amino-5-(trifluoromethyl)pyridine-2-carboxylate, 98%, 100mg

1-(4-Methyloxazol-2-yl)ethanone, 95.0%, 100mg

1-(3,5-dimethylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 2g

Indoline-1-carbaldehyde, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)

Soluzione standard Zolfo ICP, ROTI®Star, 1000 mg/l S, densità (D) ~1 g/cm³

3-(1,3-Thiazol-4-yl)Aniline, 95.0%, 1g

5-Bromo-6-chloronicotinic acid, 98.0%, 5g

tert-Butyl (1R,2S,3S,5S)-3-amino-2-fluoro-8-azabicyclo[3.2.1]octane-8-carboxylate, 98%, 500mg